Autopsy report · NCT04143841

Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease

“Financial constraints”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 2 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Epitech Mag Ltd.

Sponsor type

Industry

Conditions

Dry Eye Syndromes; ATD; Sjogren's Syndrome

Interventions

Viveye OMNS treatment; Viveye OMNS sham treatment

Participants

50

Sites

3

Countries

Israel

Trials that died the same way

• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
  “Funding constraints” (79% match in meaning)
• Assessment of a Health Informatics System on Insulin-treated Diabetic Patients
  “financial issues” (71% match in meaning)
• Thrust Versus Non-thrust Manipulation in Chronic Low Back Pain
  “Time and funding constraints” (67% match in meaning)
• SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty
  “Logistical constraints” (67% match in meaning)
• The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
  “Institutional and funding constrains” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.